You are here: Industry Insights > Australia

News List

Dubai, Australia tie up for cancer research biospectrumasia
April 26, 2018
The partnership would focus on clinical research and translation and on participating in developing a world-leading healthcare system.
Tandem announces Australia, New Zealand distribution deals biospectrumasia
April 25, 2018
Under the terms of the arrangements, the diabetes divisions of AMSL and NZMS will perform all sales, marketing, and customer training and support for Tandem’s products in the regions.
Fresenius Medical Care gets recognition by ACHS biospectrumasia
March 16, 2018
Full accreditation against the ten National Safety and Quality in Healthcare Standards as well as the five EQuIPNational Standards was awarded by ACHS in December 2017.
Kerry Corning initiates phase 1 trial for narcoleptic drug biospectrumasia
March 14, 2018
XW Laboratories Inc. has launched the first human body for the new narcoleptic drug XW10172 in Australia
Australia launches national cancer programme biospectrumasia
September 21, 2017
The program recognises that each child’s cancer is unique, so they respond differently to anticancer treatment.
Australia, Brazil, China join forces to advance research in science biospectrumasia
September 13, 2017
The collaboration for new advancements in Science, Technology and Innovation will support Brazilian researchers in collaborating with Australian partners and support institution-to-institution and researcher-to-researcher links
Australia announces new skill list biospectrumasia
August 07, 2017
Reacting to the industry voices, the Australian Government has restored the occupations that support growing Australia’s research capacity and ensure a thriving scienti c and research sector.
Roche’s Ocrevus receives TGA approval for RMS and PPMS treatment in Australia pharmaceutical-technology
July 19, 2017
The Australian Therapeutic Goods Administration (TGA) has granted approval for Roche’s Ocrevus (ocrelizumab) for the treatment of relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).
Australia’s Cochlear plans expansion in China biospectrumasia
July 17, 2017
China is already among Cochlear’s top five international markets and is its fastest growing market by volume, with potential to deliver more strong growth over the next decade.
Novogen awarded grant of up to A$3 million by Australian Federal Government for novel drug discovery pharmaasia
April 14, 2017
The grant was awarded to fund development of a next-generation anti-tropomyosin program, which is intended to provide potential new therapies for cancer.

Previous page 1 2 3 4 5 6 Next page